Genmab | GEN - Biaya Operasional





Biaya Operasional Perubahan Tanggal
Agios Pharmaceuticals USD 155.3M 24.53M 2026-06
Almirall EUR 531.16M 13.76M 2026-06
Amarin USD 51.48M 113K 2025-12
Amgen USD 5.69B 6B 2026-09
argenx SE USD 1.24B 213M 2026-09
AstraZeneca USD 11.55B 674M 2026-09
Bayer EUR 9.92B 121M 2026-09
BioMarin Pharmaceutical USD 819.04M 5.5B 2026-09
Demant DKK 10.79B 1.16B 2026-06
Exelixis USD 390.27M 10M 2026-09
Fresenius Medical Care EUR 4.55B 229.7M 2026-09
Genmab DKK 748M 77M 2026-06
GlaxoSmithKline GBP 6.03B 227M 2026-09
GN Store Nord DKK 2.11B 51M 2026-06
GRIFOLS EUR 1.65B 101M 2026-09
Hikma Pharmaceutical USD 1.34B 702M 2025-12
Insmed USD 606.26M 79.46M 2026-09
Lakefront Biotherapeutics EUR 55.62M 14.56M 2026-06
Lonza CHF 2.9B 184M 2025-06
Merck EUR 4.34B 249M 2026-06
Novartis USD 9.88B 325M 2026-09
Regeneron Pharmaceuticals USD 33.5B 1.79B 2026-09
Roche Holding CHF 18.9B 2.12B 2026-06
Sanofi EUR 10.51B 598M 2026-09
UCB EUR 2.96B 196M 2025-12